He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
CDSCO to fast-track trials and approval for COVID19 vaccine
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
Innovative solutions and a deep understanding of the market makes this a unique combination
Startup receives US $ 5 million in first round of funding
Complementary business models are the reason for the acquisition
This deal makes Meddo, one of the largest health-tech players in India
India business is growing as per projections; whereas US business will bounce back soon.
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated
